, opens new tab on Wednesday launched a new multi-year program to reduce its expenses by about $1.5 billion by the end of 2027, adding on to a $4 billion cost cutting plan it announced last year.
Pfizer Inc. (NYSE:PFE) has recently launched a multi-year cost reduction initiative aimed at saving approximately $1.5 billion by the end of 2027. This new program builds upon a $4 billion cost ...
Pfizer last year shut down operations at sites in Morrisville and Durham. The latter was a manufacturing facility focused on ...
The pharma industry is staring down the barrel of a widespread loss of exclusivity, with more than 190 products going ...
Pfizer CEO announces testing of new weight loss drugs with different mechanisms. GLP-1 agonists dominate market.
(Reuters) -U.S. drugmaker Pfizer on Wednesday launched a new multi-year program to reduce its expenses by about $1.5 billion by the end of 2027, adding on to a $4 billion cost cutting plan it ...
Pfizer PFE announced that it is launching a new cost-restructuring program to reduce its spending. Spanning across multiple years, the program intends to reduce the company’s costs of goods sold in a ...
Pfizer Inc. (NYSE:PFE) has recently launched a multi-year cost reduction initiative aimed at saving approximately $1.5 billion by the end of 2027. This new program builds upon a $4 billion cost ...